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INTRODUCTION 
The term mushroom in a broader sense refers to a group of 
macrofungi belonging to several orders like Ascomycetes or 
Basidiomycetes, thriving in a wide range of habitats like moist 
wood, organic matter and humid-rich soil or decomposed animal 
waste.  Almost 2000, out of 70,000 fungal species known all 
over the world are edible mushrooms.[1] Over time immemorial, 
they are regarded as major source of nutrient and medicine, 
with lots of health benefits. The concept of using fungus in 
medicine officially appeared first in Traditional Chinese 
Medicine and can be dated back to several thousand years 
ago. In the midst of the 20th century, some early researches were 
conducted on Boletus edulis to verify the antitumor activity of 
medicinal mushrooms.[2] Mushrooms have been found to contain 
sufficient levels of water (90%), carbohydrates (1-55%), proteins 
(2-40%) with eight important amino acids, lipids (2-8%) with 
polyunsaturated fatty acids and small amounts of saturated fatty 
acids, fibers (3-32%), ash (8-10%), volatile oils, and several 
antioxidants like phenolics, carotenoids, flavonoids and several 
vitamins like B1, B2, B3, C and ergosterol. Several biologically 
active compounds, viz., β-glucans, terpenes, and steroids 
accumulate in mushrooms, whose function depends on the type 
of mushroom, developmental stage, and growing conditions.[3] 
The most significant medicinal effect of mushrooms and 
their metabolites is their antitumor property. Prevention of 
life threatening diseases like hypercholesterolemia, cardiovascular 
disease, cerebral stroke, hypertension and atherosclerosis is 
possible due to the presence of high fiber content, microelements, 
proteins and low calorie content. The compounds extracted from 
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mushrooms possess antimicrobial, antiviral, anticancer, anti-
angiogenic, anti-neurodegenerative, antioxidant, anti-thrombotic, 
anti-inflammatory, hepatoprotective, immunomodulatory and 
hypoglycemic properties. They can reduce blood cholesterol 
and blood glucose levels.[4] Traditionally used mushrooms 
like Agaricus blazei, Ganoderma, Auricularia, Lentinus, 
Flammulina, Grifola, Trametes (Coriolus) and Tremella 
are reported to exhibit significant medicinal properties. 
Pleurotus spp. deserves special mention in this connection 
with high medicinal use and cultivated throughout the 
world because of simple and low cost production and high 
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biological efficiency.[5] Despite such immense utility, mushroom 
consumption is mostly restricted within ethnic groups or rural 
populations who are more acquainted with individual mushrooms 
and their utilities. Moreover, adequate research on mushrooms as 
potential source of medicines is largely ignored.
CHEMICALS AND COMPOUNDS OF 
MEDICINAL IMPORTANCE
Glucan polysaccharides are isolated from the mycelia 
and fruiting bodies of different mushrooms like 
Pleurotus ostreatus (pleuran), Schizophyllum commune 
(schizophyllan), Lentinula edodes (lentinan), Ganoderma 
lucidum (ganoderan A and B), as well as from Agaricus blazei, 
Caripia montagnei, Lactarius rufus and Pholiota nameko. 
Such polysaccharides activate macrophages, thereby 
enhancing immunity and exhibit anticancer, antioxidant, 
anti-inflammatory, anti-diabetic and immunomodulatory 
activities. Oxygen-derived free radicals like superoxide and 
hydroxyl radicals, hydrogen peroxide, etc., are constantly 
generated within the human body during oxidative 
metabolism and energy production, leading to the formation 
of reactive oxygen species (ROS) within the system. This 
leads to inevitable oxidative stress that causes cellular 
damages, tissue injuries and different clinical disorders 
like rheumatoid arthritis, ischemia, acute hypertension, 
myocardial infarcation and diabetes mellitus.[6] Dietary 
intake of antioxidants like phenolics can help overcome 
these abnormalities. The phenolic compounds like oxidized 
polyphenols, phenolic acids, flavonoids, hydroxybenzoic 
acid, hydroxycinnamic acids, tannins, and stilbenes can 
scavenging free radicals. Mushrooms like Hericium 
erinaceus (hericenones), Craterellus cornucopioides 
(polyphenol and myricetin), Albatrellus ovinus (grifolin 
and grifolin derivatives) and Agaricus bisporus (pyrogallol) 
provide a valuable source of such phenolics. Agaritine and 
its derivatives that chemically belong to hydrazines are 
the main aromatic compounds of A. bisporus. Agaritine 
was found to contribute to the formation of toxic aryl 
diazonium ions. Gamma-glutaminyl-4-hydroxybenzene is 
the principal phenolic compound present in mushrooms.[7] 
Terpenoids are another group of metabolites which act 
as anticancer, antioxidant, and anti-inflammatory agents. 
Triterpenes like lucidenic acids, ganoderic acids, and 
lanostane-type triterpenic acids are obtained from G. 
lucidum, while Inonotus obliquus is the source of various 
sterols and triterpenes like trametenolic acid, inotodiol, 
ergosterol, and ergosterol peroxide.[8] Several proteins and 
peptides like ribosome-inactivating proteins (RiP), lectins, 
laccases and other immunodialatory proteins isolated from 
mushrooms have clinical significances, viz., P. ostreatus 
(pleurostrin, antifungal peptide), Agrocybe cylindracea 
(agrocybin, antifungal peptide), Russula paludosa (SU2, 
antiviral peptide), Cordyceps sinensis and Cordyceps 
militaris (cordymin peptide, anti-inflammatory). By 
chemical nature, cordycepin is 30-deoxyadenosine, a purine 
alkaloid, and cordycepic acid is D-mannitol, both found in 
C. sinensis. C. militaris contains cordycepin, adenosine, 
polysaccharide, mannitol, trehalose, polyunsaturated 
fatty acids, δ-tocopherol, p-hydroxybenzoic acid, and 
β-(1→3)-D-glucan. The components like deoxynucleosides, 
produced by C. sinensis, such as the compounds 2′, 
3′ deoxyadenosine which is marketed under the trade 
name ‘Didanosine’ in the USA, is used as a medication 
for the treatment of acquired immune deficiency syndrome 
(AIDS). Similarly, quinic acid derived from cordycepin (3′ 
deoxyadenosine) is found to have antiviral and antibacterial 
properties.[9]
EXTRACTION OF MEDICINAL COMPONENTS
Ultrasound extraction in the releasing of a full spectrum 
of bioactive compounds from mushrooms within a 
comparatively short time is the most common and 
convenient technique. Compression and expansion cycles 
are formed in the extract when intense ultrasound waves, 
also called acoustic cavitation, are applied. Growing 
vacuum bubbles so formed reach a stage where they 
collapse violently, being unable to absorb further energy. 
During this phenomenon, termed bubble implosion, extreme 
conditions like high temperature, pressure gradient, and 
shearing forces are generated locally, breaking apart the 
mushroom cells releasing the polysaccharides, terpenes 
phenolics, etc. into the solvent. Cavitation is the term 
given to the formation, growth and collapse of the vacuum 
bubbles. Ultrasonic extraction can be performed in several 
solvents like methanol, ethanol, isopropanol, glycerine, 
water, water/ethanol mixture, etc.
THERAPEUTIC APPLICATIONS OF 
MUSHROOMS
As antimicrobial agent
Chloroform, petroleum ether and acetone extracts from 
Osmoporus odoratus that can act against Sterptococcus pyogenes, 
Pseudomonas aeruginosa, Staphylococcus aureus, Escherichia 
coli and Bacillus subtilis are strong antibacterial agents. The 
methanolic/ethanolic / acetone / aqueous extracts of other 
mushrooms like G. lucidum and Phellinus can also act against 
pathogens like B. subtilis, E. coli, Salmonella typhi, etc; the latter 
mushroom also act against fungal pathogens like Aspergillus 
niger, Penicillium spp, Aspergillus fumigatus, Aspergillus 
niger, Mucor indicus, and Aspergillus flavus.[10]
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As antioxidant
The ethanolic extract of G. lucidum possesses the 
antiperoxidative capacity, whereas methanolic, ethyl acetate 
and aqueous extract can inhibit uncontrolled production of 
hydroxyl and superoxide radicals that lead to the onset of 
cancer, atherosclerosis and rheumatoid arthritis.[11] 
As anti-inflammatory agent
Ethanolic extract of Morchella esculenta and ethyl acetate and 
methanolic extracts from G. lucidum are considered as potential 
anti-inflammatory agents, which have undergone trial in mice.[12]
As antitumor agents 
The antitumor property of mushrooms has been tested in 
mice model using different tumor cell lines. The β-(1-6)-
branched β-(1-3)-linked glucans, schizophyllan, lentinans and 
grifolan, all exhibit antitumor activity. The mushrooms important 
in this regard are Grifola frondosa, Schizophyllum commune, 
Lentinus edodes and Sclerotinia sclerotiorum. The methanolic / 
ethyl acetate / aqueous extract of Pleurotus rimosus also shows 
an impressive result in retarding tumor development.[13] 
As medicines
A. blazei can be used against different diseases like diabetes, 
hyperlipidemia, chronic hepatitis and cancer. Extracts 
from Pleurotus can fight against chronic diseases like 
hypercholesterolemia, hypertension, etc. G. lucidum finds regular 
use in treating patients infected with human immunodeficiency 
virus (HIV) and AIDS.[14] Specially, P. ostreatus contain high 
levels of isomers of lovastatin, which are well-known blood 
cholesterol-reducing compounds. The presence of dietary fibers, 
lectins, chitin, β-glucans and polysaccharide-protein-complex 
(PSPC) makes these mushrooms highly effective against a host of 
clinical symptoms, including renal failures, gout, dropsy, jaundice, 
night sweating in tuberculosis and intestinal infection with worms.
6. CONCLUSION AND FUTURE 
PERSPECTIVES
In spite of immense medicinal and therapeutic applications 
of mushrooms, as discussed, their potentiality is still 
under-rated or under-estimated. Moreover, many novel 
mushrooms present in nature are largely unidentified, so 
that it is necessary to study mushroom diversity and make 
a reliable database elaborately. The chemical profiling 
of the secondary metabolites of the yet uncharacterized 
mushrooms and their applications against different clinical 
symptoms will also provide a further scope of deriving 
novel bioactive compounds from mushrooms and exploiting 
them for therapeutics and medicines. It is also vital to 
conduct more in-vivo experiments and clinical trials, rather 
than merely showing their effects in in-vitro cell lines to 
generate a broader and holistic effect on the body system 
as a whole. This will throw light on the complex modes of 
interaction, synergistic interplay of bioactive compounds 
with different endogenous signaling molecules within 
human system, and their molecular targets. The words of 
Hippocrates (the father of medicine) “Let food be your 
medicine and medicine be your food” apply very aptly for 
the mushrooms which have both nutritional and medicinal 
importance, and hence regarded as valuable assets for 
human welfare.
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